Skip to content

Released Aug 9, 2016, after the close

10-Q filed Aug 9, 2016, 40 days after period end · 0001390478-16-000134

Q2 2016 · 10-Q
Revenue—
Net Income$5.39Mno prior Q2 2015 on fileN/M vs Q1 2016
EPS Diluted$0.58no prior Q2 2015 on fileno prior Q1 2016 on file
Operating Income-$9,292,000—
Operating Cash Flowderived-$11,491,000—
Free Cash Flowderived-$11,491,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2016Q2 2013Q2 2012Q2 2011
Revenue—$3.38M$3.38M—
Net Income$5.39M$5.39M-$15.66M-$3.75M
EPS Diluted$0.58-$0.11-$0.03-$0.10

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR